100¦~2¤ë¸¹ ¹D ªk ªk °T (226)

DEEP & FAR

 

 

¶i¨B©Ê¶·¨Ìªk»{©w

(Federal Circuit 2008-1073) (¤K)

 

 

³¯ºaºÖ ±M§Q¥N²z¤H

¡E¤¤°êÂåÃľǰ|ÃľǨt¾Ç¤h

¡E¤é¥»ºÖ©£¤j¾Ç¥ÍÃľǩҺӤh

¡E¶§©ú¤j¾ÇÂå¾ÇÃIJz©Ò³Õ¤h

 

 

µM¦Ó¡A²ßª¾§Þ³N¤§¸Ë¸m¡A®Ú¾Ú¥Ó½Ð¤H¡A«Y«ü¡u¥]§t¶î¼h¤§ÃĪ«....¥Î©óª÷Äݤä¬[¡v¡C[1]¦]¦¹¡A¦pªG¸Ó­×¥¿¥²¶·©ó¥ô¦óªF¦è­°§C¾®¦å¬¡©Ê¡A«hÀ³§C©ó¤w¶î¼h¤§²ßª¾§Þ³N¤ä¬[¡A¦Ó«D²ßª¾§Þ³N¤§»rª÷Äݤä¬[¡C¦]¦¹¥Ó½Ð¤H¤£¥i¯à¤w¦Ò¼{¡uµL¦å¤pªOÂHªþ¡v¦Ó­n¨D©ó¤@»rª÷Äݤä¬[¤§¾®¦å¬¡©Ê¡C

Cordis¥çª§ÅG¡A¦a¤èªk°|¤£À³¸Ó¤ñ¸ûÃã¨å¤¤¡uthrombogenic¡v»P¡uthrombolytic¡v¤§©w¸q¡A¦]¬°¡uthrombolytic¡v¨Ã¥¼¥X²{©ó½Ð¨D¶µ¡A¥B¦]¬°¨ä©ó»¡©ú®Ñ»P¡unon-thrombogenic¡vµø¬°¦P¸qµü¡C§Ú­Ì¤£¦P·N¡Cªk°|·íµM¥i¡u¨Ì·ÓÃã¨å©w¸q¡A¥H¸ÑŪ½Ð¨D¶µ³N»y¡A¥u­nÃã¨å¤§©w¸q¤£¬»Ä²¥ô¦ó©óŪ¨ú±M§Q¤å¥ó®É©Ò»{©w©Î½T©w¤§©w¸q¡v[2]¡A¥Bªk°|©ó¨Ì·ÓÃã¨å©w¸q¸ÑÄÀ½Ð¨D¶µ³N»y¤§·N¸q¨Ã¥¼¥Ç¿ù¡C¦a¤èªk°|¥iÀò­ã±q¡uthrombogenic¡v©M¡uthrombolytic¡v¤§©w¸q¥H¸ÑÄÀ¡unon-thrombogenic¡v¤§·N¸q¡C¥Ñ©óªk°|¤§©w¸q»P»¡©ú®Ñ¡B¥Ó½Ð¾ú¥v©M¬ÛÃö³N»y¤§Ãã¨å©w¸q¤@­P¡A§Ú­ÌªÖ©w¦a¤èªk°|¹ï©ó³N»y¡unon-thrombogenic¡v¤§©w¸q¡C¦]¦¹§Ú­Ì¤£»Ý­n½×­z¡A¦b½Ð¨D¶µ¤£¦P¸ÑŪ¤U¡ACypher¤ä¬[¨Ã¥¼«I¥Ç¡¦536±M§Q½Ð¨D¶µ²Ä8¶µ¤§Cordis½×¾Ú¡C

 

2. ¡uªø´Á¶¡¡v¤§¸ÑŪ

Cordis¥çª§ÅG¡A¦a¤èªk°|¿ù»~¦a¸ÑŪ¡uªø´Á¶¡¡v«Y¡u¤@¬q´Á¶¡¡v¤§·N«ä¡A¥BÀÝÅv¦a»é¦^Cordis°ò©ó·sµo²{¼Æ¾Ú´£¥X·s¼f§P¤§Án½Ð¡C®Ú¾ÚCordisºÙ¡A¦a¤èªk°|¤§¸ÑŪ¤£·í¦a§R±¼½Ð¨D¶µ¡uªø´Á¶¡¡v¤§­n¥ó¡A¦]¬°½Ð¨D¶µ­n¨D¡uªø´Á¶¡¤§µL¾®¦å¬¡©Ê¡v¡A¥H¤Î¡u¦bÄÀ¥X¸Ó¥Í²z¬¡©Êª«½è¤§«á©Î´Á¶¡¤§®É¬q¤º¡v´£¨ÑµL¾®¦å¬¡©Ê¨âªÌ¡A¦Óªk°|¤§©w¸q¶È­n¨D¡u©µ¦ù¤Î©ó¦bÄÀ¥X¸Ó¥Í²z¬¡©Êª«½è¤§«á©Î´Á¶¡¨âªÌ¤§®É¬q¤º¡v¡C

  



[1]. Parties¡¦ Joint App. at A482 (prosecution history of ¡¦536 patent, amendment dated July 30, 1997).

[2]. Phillips, 415 F.3d at 1322¡V23,